{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:57Z","timestamp":1790912517003,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41409-026-02948-4","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:45:34Z","timestamp":1782287134000},"page":"1182-1187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety, efficacy and feasibility of GCSF and plerixafor based CD34 mobilization for backup autologous stem cell collection in patients undergoing alternate donor hematopoietic stem cell transplant for sickle cell disease: Take away lessons for gene therapy"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7258-6659","authenticated-orcid":false,"given":"Garima","family":"Nirmal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhav","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eby P.","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2181-1825","authenticated-orcid":false,"given":"Gaurav","family":"Kharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2948_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","volume":"15","author":"R Szydlo","year":"1997","unstructured":"Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15:1767\u201377.","journal-title":"J Clin Oncol"},{"key":"2948_CR2","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","volume":"5","author":"J Kanter","year":"2021","unstructured":"Kanter J, Liem RI, Bernaudin F, Bola\u00f1os-Meade J, Fitzhugh CD, Hankins JS, et al. American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation. Blood Adv. 2021;5:3668.","journal-title":"Blood Adv"},{"key":"2948_CR3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.bbmt.2008.06.005","volume":"14","author":"A Dew","year":"2008","unstructured":"Dew A, Collins D, Artz A, Rich E, Stock W, Swanson K, et al. Paucity of HLA-Identical Unrelated donors for African-Americans with Hematologic Malignancies: The Need for New Donor Options. Biol Blood Marrow Transpl. 2008;14:938.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2948_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","volume":"3","author":"JN Barker","year":"2019","unstructured":"Barker JN, Boughan K, Dahi PB, Devlin SM, Maloy MA, Naputo K, et al. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis. Blood Adv. 2019;3:939\u201344.","journal-title":"Blood Adv"},{"key":"2948_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1182\/asheducation-2013.1.370","volume":"2013","author":"E Gluckman","year":"2013","unstructured":"Gluckman E. Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease. Hematology. 2013;2013:370\u20136. https:\/\/doi.org\/10.1182\/asheducation-2013.1.370.","journal-title":"Hematology"},{"key":"2948_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41409-020-01054-3","volume":"56","author":"G Kharya","year":"2021","unstructured":"Kharya G, Bakane A, Agarwal S, Rauthan A. Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease. Bone Marrow Transpl. 2021;56:492\u2013504.","journal-title":"Bone Marrow Transpl"},{"key":"2948_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1182\/hematology.2023000486","volume":"2023","author":"AA Kassim","year":"2023","unstructured":"Kassim AA, DeBaun MR. The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally. Hematology. 2023;2023:532\u201341. https:\/\/doi.org\/10.1182\/hematology.2023000486.","journal-title":"Hematology"},{"key":"2948_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaci.2015.11.028","volume":"138","author":"M Weisser","year":"2016","unstructured":"Weisser M, Demel UM, Stein S, Chen-Wichmann L, Touzot F, Santilli G, et al. Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions. J Allergy Clin Immunol. 2016;138:219\u201328.e9.","journal-title":"J Allergy Clin Immunol"},{"key":"2948_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/14653240902849788","volume":"11","author":"CD Fitzhugh","year":"2009","unstructured":"Fitzhugh CD, Hsieh MM, Bolan CD, Saenz C, Tisdale JF. Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: Time for a moratorium? Cytotherapy. 2009;11:464\u201371.","journal-title":"Cytotherapy"},{"key":"2948_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/scd.2016.0230","volume":"26","author":"M Cavazzana","year":"2017","unstructured":"Cavazzana M, Ribeil JA, Lagresle-Peyrou C, Andr\u00e9-Schmutz I. Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow\u2019s Point of View. Stem Cells Dev. 2017;26:71\u20136.","journal-title":"Stem Cells Dev"},{"key":"2948_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1537-2995.2012.03751.x","volume":"53","author":"TF Wang","year":"2013","unstructured":"Wang TF, Chen SH, Yang SH, Su YC, Chu SC, Li DK. Poor harvest of peripheral blood stem cell in donors with microcytic red blood cells. Transfusion. 2013;53:91\u20135.","journal-title":"Transfusion"},{"key":"2948_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.bbmt.2008.03.001","volume":"14","author":"C Rosenbaum","year":"2025","unstructured":"Rosenbaum C, Peace D, Rich E, Van Besien K. Granulocyte Colony-Stimulating Factor-Based Stem Cell Mobilization in Patients with Sickle Cell Disease. Biol Blood Marrow Transpl. 2025;14:719\u201323.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2948_CR13","doi-asserted-by":"publisher","first-page":"E239","DOI":"10.1002\/ajh.25867","volume":"95","author":"JF Tisdale","year":"2020","unstructured":"Tisdale JF, Pierciey FJ, Bonner M, Thompson AA, Krishnamurti L, Mapara MY, et al. Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial. Am J Hematol. 2020;95:E239\u201342.","journal-title":"Am J Hematol"},{"key":"2948_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1182\/blood-2019-128894","volume":"134","author":"J Kanter","year":"2019","unstructured":"Kanter J, Tisdale JF, Mapara MY, Kwiatkowski JL, Krishnamurti L, Schmidt M, et al. Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1\/2 Hgb-206 Group C Study. Blood. 2019;134:990.","journal-title":"Blood"},{"key":"2948_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3324\/haematol.2019.236182","volume":"105","author":"N Uchida","year":"2020","unstructured":"Uchida N, Leonard A, Stroncek D, Panch SR, West K, Molloy E, et al. Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor. Haematologica. 2020;105:497\u2013501.","journal-title":"Haematologica"},{"key":"2948_CR16","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1182\/bloodadvances.2021004232","volume":"5","author":"A Leonard","year":"2021","unstructured":"Leonard A, Sharma A, Uchida N, Stroncek D, Panch SR, West K, et al. Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease. Blood Adv. 2021;5:2403\u201311. https:\/\/doi.org\/10.1182\/bloodadvances.2021004232.","journal-title":"Blood Adv"},{"key":"2948_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1705431","volume":"38","author":"P Fu","year":"2006","unstructured":"Fu P, Bagai RK, Meyerson H, Kane D, Fox RM, Creger RJ, et al. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transpl. 2006;38:189\u201396.","journal-title":"Bone Marrow Transpl"},{"key":"2948_CR18","first-page":"204","volume":"38","author":"H Demiro\u011flu","year":"2025","unstructured":"Demiro\u011flu H, \u00c7ift\u00e7iler R, B\u00fcy\u00fcka\u015f\u0131k Y, G\u00f6ker H. Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma. Turkish J Hematol. 2025;38:204.","journal-title":"Turkish J Hematol"},{"key":"2948_CR19","doi-asserted-by":"crossref","unstructured":"Melve GK, Ersvaer E, Eide GE, Kristoffersen EK, Bruserud \u00d8. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets. Front Immunol [Internet]. 2018 [cited 2025 Mar 22];9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29770133\/.","DOI":"10.3389\/fimmu.2018.00845"},{"key":"2948_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","volume":"57","author":"JA Snowden","year":"2022","unstructured":"Snowden JA, S\u00e1nchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transpl. 2022;57:1217\u201339.","journal-title":"Bone Marrow Transpl"},{"key":"2948_CR21","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1182\/bloodadvances.2018016725","volume":"2","author":"EB Esrick","year":"2018","unstructured":"Esrick EB, Manis JP, Daley H, Baricordi C, Tr\u00e9b\u00e9den-Negre H, Pierciey FJ, et al. Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients. Blood Adv. 2018;2:2505\u201312.","journal-title":"Blood Adv"},{"key":"2948_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3324\/haematol.2016.147132","volume":"102","author":"J Pantin","year":"2017","unstructured":"Pantin J, Purev E, Tian X, Cook L, Donohue-Jerussi T, Cho E, et al. Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trial. Haematologica. 2017;102:600\u20139.","journal-title":"Haematologica"},{"key":"2948_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bjh.18311","volume":"198","author":"A Sharma","year":"2022","unstructured":"Sharma A, Leonard A, West K, Gossett JM, Uchida N, Panch S, et al. Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease. Br J Haematol. 2022;198:740\u20134.","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02948-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02948-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02948-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:37:32Z","timestamp":1789119452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-026-02948-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1038\/s41409-026-02948-4","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"For patients <12 years, consent was taken from either of the parents, for patients 12-18 years written and informed assent along with parents\u2019 consent was taken and patients >18 years signed the consent on their own after detailed counselling. Informed consent about data sharing and its use for analytical research and publication was taken for all the patients from a competent person in accordance with the Helsinki declaration. The use of laboratory and clinical data was approved by institutional ethics committee (IAH BMR\/028\/06-25). All the data was anonymized prior to analysis.","order":2,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}